Figlin Ra

507 total citations
15 papers, 248 citations indexed

About

Figlin Ra is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Figlin Ra has authored 15 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Figlin Ra's work include Renal cell carcinoma treatment (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Figlin Ra is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Figlin Ra collaborates with scholars based in United States, United Kingdom and France. Figlin Ra's co-authors include Gregory Sarna, Arie S. Belldegrun, David Parkinson, M. Linehan, Robert H. Wiltrout, Walter E. DeWolf, Jean B. deKernion, Peter F.A. Mulders, Alicia V. Palleroni and Loretta M. Itri and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of Oncology.

In The Last Decade

Figlin Ra

14 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Figlin Ra United States	8	112	101	91	67	50	15	248
D-S Bae South Korea	9	130 1.2×	72 0.7×	62 0.7×	27 0.4×	63 1.3×	20	372
Chang Hun Lee South Korea	11	92 0.8×	172 1.7×	86 0.9×	93 1.4×	74 1.5×	29	341
Ajit Paintal United States	12	91 0.8×	99 1.0×	128 1.4×	31 0.5×	55 1.1×	24	333
Feiteng Lu China	12	118 1.1×	102 1.0×	57 0.6×	63 0.9×	77 1.5×	21	306
Nooshin Hashemi Sadraei United States	10	130 1.2×	199 2.0×	66 0.7×	60 0.9×	30 0.6×	30	321
Francesca Sparano Italy	9	113 1.0×	219 2.2×	103 1.1×	78 1.2×	65 1.3×	19	369
Yuichi Ando Japan	9	119 1.1×	130 1.3×	76 0.8×	32 0.5×	32 0.6×	47	301
Aurora Rizzo Italy	9	167 1.5×	148 1.5×	48 0.5×	66 1.0×	40 0.8×	10	322
Yuji Hirami Japan	10	96 0.9×	222 2.2×	162 1.8×	145 2.2×	74 1.5×	21	405
Α. Kotsakis Greece	11	132 1.2×	223 2.2×	147 1.6×	65 1.0×	53 1.1×	23	338

Countries citing papers authored by Figlin Ra

Since Specialization

Citations

This map shows the geographic impact of Figlin Ra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Figlin Ra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Figlin Ra more than expected).

Fields of papers citing papers by Figlin Ra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Figlin Ra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Figlin Ra. The network helps show where Figlin Ra may publish in the future.

Co-authorship network of co-authors of Figlin Ra

This figure shows the co-authorship network connecting the top 25 collaborators of Figlin Ra. A scholar is included among the top collaborators of Figlin Ra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Figlin Ra. Figlin Ra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ra, Figlin, et al.. (2017). Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?. Annals of Oncology. 29(2). 324–331. 15 indexed citations

Korytowsky, Beata, et al.. (2016). The Social Value of Immunotherapy in Non-Small Cell Lung Cancer. Value in Health. 19(3). A167–A167. 1 indexed citations

Lu, Dongrui R., et al.. (2011). Response: Re: Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib. JNCI Journal of the National Cancer Institute. 103(20). 1558–1558.

Reckamp, Karen L., Mihaela Cristea, Brian Gardner, et al.. (2010). Randomized, placebo-controlled, phase II trial of EGFR and COX-2 inhibition in advanced non-small cell lung cancer.. Journal of Clinical Oncology. 28(15_suppl). TPS337–TPS337. 2 indexed citations

Goodnight, James E., et al.. (2006). Practice guidelines for pancreatic cancer.. PubMed. 2(3A Suppl). S53–60. 3 indexed citations

Elias, Laurence, et al.. (2002). Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-α for the treatment of patients with advanced renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 7(2). 83–83. 1 indexed citations

Belldegrun, Arie S., Oleg Shvarts, & Figlin Ra. (2000). Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma.. PubMed. 6 Suppl 1. S88–92. 25 indexed citations

Ra, Figlin, Scott Parker, & Holly M. Horton. (1999). Technology evaluation: interleukin-2 gene therapy for the treatment of renal cell carcinoma.. PubMed. 1(2). 271–8. 7 indexed citations

Mulders, Peter F.A., Figlin Ra, Jean B. deKernion, et al.. (1997). Renal cell carcinoma: recent progress and future directions.. PubMed. 57(22). 5189–95. 86 indexed citations

10.

Ra, Figlin, et al.. (1988). Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation.. Journal of Clinical Oncology. 6(10). 1604–1610. 52 indexed citations

11.

Ra, Figlin. (1988). Biotherapy with interferon--1988.. PubMed. 15(6 Suppl 6). 3–9. 15 indexed citations

12.

Ra, Figlin. (1987). Biotherapy with interferon in solid tumors.. PubMed. 14(6 Suppl). 23–31. 3 indexed citations

13.

Sarna, Gregory, et al.. (1986). Phase I study of recombinant beta ser 17 interferon in the treatment of cancer.. PubMed. 70(12). 1365–72. 19 indexed citations

14.

Sarna, Gregory, Figlin Ra, & Susan McCarthy. (1983). Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.. PubMed. 2(2). 187–95. 2 indexed citations

15.

Sarna, Gregory, Figlin Ra, & Michael U. Callaghan. (1983). Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.. PubMed. 2(4). 343–7. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact